Combination of Bendamustine, Lenalidomide, and Dexamethasone (BLD) in Patients with Refractory or Relapsed Multiple Myeloma Is Safe and Highly Effective: Results of Phase I/II Open-Label, Dose Escalation Study

Autor:	Lentzsch, Suzanne, O'Sullivan, Amy *, Kennedy, Ryan *, Abbas, Mohammad *, Gill, Navkiranjit *, Dai, Lijun *, Andreas, Carrie *, Gardner, Diane *, Pregja, Silvana Lalo *, Burt, Steve *, Redner, Robert L., Volkin, Robert *, Roodman, G. David *, Mapara, Markus Y., Viverette, J. Franklin *, Agha, Mounzer, Waas, John K., Shuai, Yongli *, Normolle, Daniel *, Zonder, Jeffrey A.
Zdroj:	In Blood 18 November 2011 118(21):304-304
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu